Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thermo Electron/Puritan-Bennett

This article was originally published in The Gray Sheet

Executive Summary

Thermo terminates its tender offer to pay $24.50 per share for all outstanding shares of P-B. The offer had been extended twice by Thermo, most recently on Nov. 28 ("The Gray Sheet" Dec. 5, In Brief). Thermo's bid, initiated Oct. 25, was contingent upon approval by P-B's board and the removal by P-B of certain anti- takeover provisions. Not having received either, Thermo says it will return to P-B shareholders the approximately 72% of outstanding P-B shares that were tendered

Latest Headlines
See All
UsernamePublicRestriction

Register

MT003197

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel